
    
      Patients with chronic heart failure in stable clinical condition treated with ACE-inhibitors,
      but not aspirin, will be evaluated by means of maximal cardiopulmonary exercise test and lung
      function including lung diffusion measurements. These tests will be done before and after
      rapid 500 ml isotonic saline infusion. Patients will be grouped according to their ACE
      genotype.
    
  